Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

ENT Devices Companies

ENT (Ear, Nose, and Throat) devices are medical devices used in the diagnosis, treatment, and management of conditions related to the ear, nose, throat, and related structures.

ENT Devices CompaniesLatest ENT Devices Companies Update



  • October 2023: The US Food and Drug Administration (FDA) granted Galen Robotics authorization and a De Novo classification grant for the Galen ES Robotic System. With the authorization, the device may be marketed for application in rigid microlaryngeal procedures. The purpose of the novel surgical assist device powered cooperatively is to facilitate ear, nose, and throat (ENT) procedures. ENT surgical procedures, such as instrument implantation and the utilization of microlaryngeal alligator forceps, are within its scopes. The instrument is precisely and steadily positioned by the device in accordance with the surgeon's movements; the surgeon retains direct physical control over the instrument throughout. Additionally, Galen ES offers the possibility of instrument stability during critical microlaryngeal procedures. Its objective is to improve patient outcomes through the provision of sophisticated features and rapid setup time that augment the capabilities of otolaryngologists.




  • January 2023: EndoTheia Inc., a medical device company headquartered in the US, received a Breakthrough Device designation from the FDA in January 2023. This designation grants the company priority status with the FDA for its technology, which significantly enhances minimally invasive flexible endoscopic surgery. This designation has been bestowed upon only the seventh device in the category of Ear Nose and Throat (ENT) devices in history. The designation will facilitate the regulatory process, allowing EndoTheia to introduce its innovative solution to physicians and patients in a timely manner. This technological advancement utilizes laser-machined metallic tubes with exceptionally thin walls to fabricate steerable, highly flexible devices capable of traversing conventional endoscopes while simultaneously housing interventional instruments. The provision of steerability to endoscope-delivered instruments by these devices paves the way for novel therapeutic and diagnostic applications of flexible endoscopy.


List of ENT Devices Key companies in the market

  • Atos Medical AB

  • Cochlear Limited

  • Hoya Corporation

  • Johnson & Johnson Services Inc.

  • Karl Storz Gmbh & Co. Kg

  • Medtronic PLC

  • Olympus Corporation

  • Rion Co. Ltd

  • Siemens Healthcare

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.